Skip to main content
. Author manuscript; available in PMC: 2016 Sep 26.
Published in final edited form as: Invest New Drugs. 2016 May 26;34(4):481–489. doi: 10.1007/s10637-016-0364-5

Table 3. Treatment Related Toxicities.

This table demonstrates the numbers of events of major toxicities observed in patients treated with docetaxel and AT-101 for HNSCC

Grade 1–2

TOXICITY Overall Arm A (Docetaxel) Arm B (Pulse Dose AT-101) Arm C (Metronomic AT-101)

Anemia 39 17 14 8
Lymphopenia 33 9 15 9
Fatigue 15 7 5 3
Thrombocytopenia 7 4 1 2
Alopecia 4 2 1 1
Nausea 3 0 3 0
Neutropenia 2 2 0 0
Grade 3–4

TOXICITY Overall Arm A (Docetaxel) Arm B (Pulse Dose AT-101) Arm C (Metronomic AT-101)

Lymphopenia 11 4 4 3
Anemia 5 4 1 0
Nausea 2 1 1 0
Vomiting 1 0 1 0
Peripheral Edema 1 0 1 0
Hypoxia 1 0 0 1
Neutropenia 4 3 1 0